PNC Financial Services Group’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $764K | Sell |
|
|||||
|
2025
Q1 | $924K | Sell |
|
|||||
|
2024
Q4 | $946K | Sell |
|
|||||
|
2024
Q3 | $1.06M | Sell |
|
|||||
|
2024
Q2 | $997K | Sell |
|
|||||
|
2024
Q1 | $1.22M | Buy |
|
|||||
|
2023
Q4 | $1.15M | Sell |
|
|||||
|
2023
Q3 | $1.56M | Sell |
|
|||||
|
2023
Q2 | $1.67M | Sell |
|
|||||
|
2023
Q1 | $1.79M | Sell |
|
|||||
|
2022
Q4 | $1.85M | Sell |
|
|||||
|
2022
Q3 | $2.16M | Sell |
|
|||||
|
2022
Q2 | $2.28M | Buy |
|
|||||
|
2022
Q1 | $2.45M | Buy |
|
|||||
|
2021
Q4 | $2.34M | Buy |
|
|||||
|
2021
Q3 | $1.17M | Sell |
|
|||||
|
2021
Q2 | $1.47M | Buy |
|
|||||
|
2021
Q1 | $1.19M | Sell |
|
|||||
|
2020
Q4 | $1.27M | Sell |
|
|||||
|
2020
Q3 | $1.38M | Sell |
|
|||||
|
2020
Q2 | $1.41M | Buy |
|
|||||
|
2020
Q1 | $1.11M | Sell |
|
|||||
|
2019
Q4 | $1.47M | Sell |
|
|||||
|
2019
Q3 | $1.16M | Buy |
|
|||||
|
2019
Q2 | $824K | Buy |
|
|||||
|
2019
Q1 | $344K | Sell |
|
|||||
|
2018
Q4 | $1.28M | Buy |
|
|||||
|
2018
Q3 | $1.29M | Buy |
|
|||||
|
2018
Q2 | $672K | Buy |
|
|||||
|
2018
Q1 | $38K | Sell |
|
|||||
|
2017
Q4 | $48K | Sell |
|
|||||
|
2017
Q3 | $310K | Hold |
|
|||||
|
2017
Q2 | $315K | Sell |
|
|||||
|
2017
Q1 | $310K | Buy |
|
|||||
|
2016
Q4 | $283K | Hold |
|
|||||
|
2016
Q3 | $320K | Hold |
|
|||||
|
2016
Q2 | $301K | Buy |
|
|||||
|
2016
Q1 | $188K | Sell |
|
|||||
|
2015
Q4 | $252K | Sell |
|
|||||
|
2015
Q3 | $435K | Buy |
|
|||||
|
2015
Q2 | $573K | Sell |
|
|||||
|
2015
Q1 | $605K | Buy |
|
|||||
|
2014
Q4 | $374K | Buy |
|
|||||
|
2014
Q3 | $192K | Hold |
|
|||||
|
2014
Q2 | $188K | Hold |
|
|||||
|
2014
Q1 | $170K | Hold |
|
|||||
|
2013
Q4 | $160K | Hold |
|
|||||
|
2013
Q3 | $140K | Hold |
|
|||||
|
2013
Q2 | $128K | Buy |
|